
| ASSET | DATE | % RETURN |
|---|---|---|
QuantaSing Group Limited American Depositary Shares (QSG) | 1/1/2024 - 1/31/2024 | 127.65% |
Here (HERE) | 1/1/2024 - 1/31/2024 | 127.65% |
Exodus Movement (EXOD) | 1/1/2024 - 1/31/2024 | 119.57% |
Akso Health Group ADR (AHG) | 1/1/2024 - 1/31/2024 | 95.24% |
ADC Therapeutics (ADCT) | 1/1/2024 - 1/31/2024 | 87.95% |
Dianthus Therapeutics (DNTH) | 1/1/2024 - 1/31/2024 | 84.81% |
Real Brokerage (REAX) | 1/1/2024 - 1/31/2024 | 79.25% |
Astria Therapeutics (ATXS) | 1/1/2024 - 1/31/2024 | 72.58% |
SEALSQ (LAES) | 1/1/2024 - 1/31/2024 | 63.33% |
Mereo BioPharma Group PLC ADR (MREO) | 1/1/2024 - 1/31/2024 | 62.66% |
Neurogene (NGNE) | 1/1/2024 - 1/31/2024 | 55.62% |
Cullinan Oncology LLC (CGEM) | 1/1/2024 - 1/31/2024 | 50.2% |
PepGen (PEPG) | 1/1/2024 - 1/31/2024 | 47.94% |
Neuropace (NPCE) | 1/1/2024 - 1/31/2024 | 45.76% |
Bright Minds Biosciences (DRUG) | 1/1/2024 - 1/31/2024 | 44.97% |
Verastem (VSTM) | 1/1/2024 - 1/31/2024 | 44.35% |
Intuitive Machines (LUNR) | 1/1/2024 - 1/31/2024 | 43.73% |
Axogen (AXGN) | 1/1/2024 - 1/31/2024 | 43.05% |
Ardelyx (ARDX) | 1/1/2024 - 1/31/2024 | 42.18% |
Keros Therapeutics (KROS) | 1/1/2024 - 1/31/2024 | 41.91% |
Abacus Life (ABL) | 1/1/2024 - 1/31/2024 | 41.64% |
Kura Oncology (KURA) | 1/1/2024 - 1/31/2024 | 39.18% |
Alliance Entertainment Holding Corporation Class A Common Stock (AENT) | 1/1/2024 - 1/31/2024 | 38.46% |
Yirendai (YRD) | 1/1/2024 - 1/31/2024 | 37.82% |
Akebia Ther (AKBA) | 1/1/2024 - 1/31/2024 | 37.7% |